Stock Events

Illumina 

€129.78
1
+€6.04+4.88% Today

Statistics

Day High
129.78
Day Low
129.78
52W High
136.62
52W Low
86.93
Volume
2
Avg. Volume
20
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1ILMN.MI. It's not an investment recommendation.

About

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. The company has strategic partnership with Myriad Genetics to broaden access to HRD testing. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
Show more...
CEO
Dr. Joydeep Goswami M.B.A., Ph.D.
Employees
10590
Country
US
ISIN
US4523271090
WKN
000927079

Listings